Stephen Paul Abelow

Dr. Stephen Paul Abelow


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2023 in Journal of ISAKOS
Verified
Journal Article
Open access
JJJohn D. Robinson Jr.
John D. Robinson Jr.
TWTyler Williamson
Tyler Williamson
TCTaylor Carson
Taylor Carson
RWRyan Whelan
Ryan Whelan
SAStephen Paul Abelow
Stephen Paul Abelow
BGBrian B. Gilmer
Brian B. Gilmer
The renewed interest in ACL repair over the last two decades stems from advances in modern arthroscopic techniques and clinical studies that have provided evidence that the ACL can reliably heal, and patients can return to sport (RTS) at a comparable rate to ACL reconstruction (ACLR) patients. The ability to maintain and utilize native ACL tissue, with proprioceptive capabilities, and the smaller drill tunnels needed to repair an ACL leads to an overall less invasive procedure and improved early rehabilitation. Additionally, repair avoids the variety of comorbidities associated with autograft harvest. This current concept review details modern techniques of ACL repair and their current studies, a review on the use of biologic enhancement in ACL repair, and other considerations to appropriately integrate ACL repair into the sports medicine orthopedic surgeon's practice.

13 September 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
PGPedro Guillén-García
Pedro Guillén-García
IGIsabel Guillén-Vicente
Isabel Guillén-Vicente
ERElena Rodríguez-Iñigo
Elena Rodríguez-Iñigo
MGMarta Guillén-Vicente
Marta Guillén-Vicente
TFTomás Fernando Fernández-Jaén
Tomás Fernando Fernández-Jaén
PGPedro Guillen
Pedro Guillen
Hyaline cartilage’s inability to self-repair can lead to osteoarthritis and joint replacement. Various treatments, including cell therapy, have been developed for cartilage damage. Autologous chondrocyte implantation (ACI) is considered the best option for focal chondral lesions. In this article, we aimed to create a narrative review that highlights the evolution and enhancement of our chondrocyte implantation technique: High-Density-ACI (HD-ACI) Membrane-assisted Autologous Chondrocyte Implantation (MACI) improved ACI using a collagen membrane as a carrier. However, low cell density in MACI resulted in softer regenerated tissue. HD-ACI was developed to improve MACI, implanting 5 million chondrocytes per cm2, providing higher cell density. In animal models, HD-ACI formed hyaline-like cartilage, while other treatments led to fibrocartilage. HD-ACI was further evaluated in patients with knee or ankle defects and expanded to treat hip lesions and bilateral defects. HD-ACI offers a potential solution for cartilage defects, improving outcomes in regenerative medicine and cell therapy. HD-ACI, with its higher cell density, shows promise for treating chondral defects and advancing cartilage repair in regenerative medicine and cell therapy.

19 March 2025 in Tissue and Cell
Verified
Journal Article
Closed access
IGIsabel Guillén-Vicente
Isabel Guillén-Vicente
ERElena Rodríguez-Íñigo
Elena Rodríguez-Íñigo
MGMarta Guillén-Vicente
Marta Guillén-Vicente
ESEnrique Samper
Enrique Samper
PGPedro Guillen
Pedro Guillen
PGPedro Guillén-García
Pedro Guillén-García

22 May 2014
Verified
Book Chapter
Closed access
PDF file
SAStephen Paul Abelow
Stephen Paul Abelow
PGPedro Guillen
Pedro Guillen
IGIsabel Guillen
Isabel Guillen
MGMarta Guillen
Marta Guillen
SRSantiago Arauz de Robles
Santiago Arauz de Robles
JAJuan Manuel Lopez Alcorocho
Juan Manuel Lopez Alcorocho